Patents by Inventor Jack BERGMAN

Jack BERGMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using muscarinic antagonists in the treatment of depression
    Patent number: 12396988
    Abstract: Muscarinic antagonist are provided that are used in the treatment of depression in a subject, such as humans. The muscarinic antagonist of the invention can relieve depression without effecting cognitive functions in the treated subject.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: August 26, 2025
    Assignees: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, UNIVERSITY OF MARYLAND, BALTIMORE, THE MCLEAN HOSPITAL CORPORATION, THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Andrew Coop, Chad R. Johnson, Jack Bergman, Brian D. Kangas, James H. Woods, Emily M. Jutkiewicz, Gail Winger
  • METHODS OF USING MUSCARINIC ANTAGONISTS IN THE TREATMENT OF DEPRESSION
    Publication number: 20220152005
    Abstract: Muscarinic antagonist are provided that are used in the treatment of depression in a subject, such as humans. The muscarinic antagonist of the invention can relieve depression without effecting cognitive functions in the treated subject.
    Type: Application
    Filed: April 6, 2020
    Publication date: May 19, 2022
    Inventors: Andrew COOP, Chad R. Johnson, Jack BERGMAN, Brian D. KANGAS, James H. WOODS, Emily M. JUKIEWICZ, Gail WINGER